IT 901 is primarily used in the field of medical research, particularly in the study of cancer therapies. It functions as a selective inhibitor targeting specific proteins involved in cell signaling pathways that are often dysregulated in cancer cells. This makes it a valuable tool for investigating potential treatments that can halt the proliferation of cancer cells or induce apoptosis. Researchers utilize IT 901 to understand the mechanisms of action of these pathways and to develop targeted therapies that minimize damage to healthy cells. Additionally, it is employed in preclinical studies to assess its efficacy and safety in various cancer models, paving the way for potential clinical applications.